Galantamine improves gait performance in patients with Alzheimer's disease

J Am Geriatr Soc. 2008 May;56(5):946-7. doi: 10.1111/j.1532-5415.2008.01657.x.
No abstract available

Publication types

  • Controlled Clinical Trial
  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / diagnosis
  • Alzheimer Disease / drug therapy*
  • Attention / drug effects
  • Cholinesterase Inhibitors / therapeutic use*
  • Female
  • Gait / drug effects*
  • Galantamine / therapeutic use*
  • Humans
  • Male
  • Mental Status Schedule
  • Neurologic Examination / drug effects
  • Neuropsychological Tests
  • Nootropic Agents / therapeutic use*

Substances

  • Cholinesterase Inhibitors
  • Nootropic Agents
  • Galantamine